MoonLake Immunotherapeutics MLTX Principal pension plans – net (Note 13)
Principal pension plans – net (Note 13) at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:PensionExpenseReversalOfExpenseNoncash.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's principal pension plans – net (note 13).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's principal pension plans – net (note 13)?
- MoonLake Immunotherapeutics (MLTX) reported principal pension plans – net (note 13) of $11K in Q1 2026.
- How has MoonLake Immunotherapeutics's principal pension plans – net (note 13) changed year-over-year?
- MoonLake Immunotherapeutics's principal pension plans – net (note 13) increased by 375.0% year-over-year, from -$4K to $11K.
- What is the long-term trend for MoonLake Immunotherapeutics's principal pension plans – net (note 13)?
- Over 3 years (2022 to 2025), MoonLake Immunotherapeutics's principal pension plans – net (note 13) has grown at a -42.4% compound annual growth rate (CAGR), from $304.03K to -$58K.